Almost 6 months on Oral fin and Oral Min HAIRLINE
    8/16/2026

    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) 1.25mg daily almost 6 months
    💊 Minoxidil (oral) 5mg daily almost 6 months
    💧 Ketoconazole shampoo (topical) 1x weekly almost 6 months
    💧 Dermastamp (topical)
    the tone is 😀 positive with significant hairline improvement results.

    Other terms

    The user experienced significant hairline improvement after almost six months using 1.25mg oral finasteride daily, 5mg oral minoxidil, and ketoconazole shampoo weekly, with side effects including increased body hair growth. They plan to switch to dutasteride and finasteride, and have stopped using a dermastamp due to irritation.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results

      research Update Treatment of Male Androgenetic Alopecia

      March 2021 in “Berkala Ilmu Kesehatan Kulit dan Kelamin”
      This review discusses the treatment options for male androgenetic alopecia, including FDA-approved therapies and new possibilities, but reports no new clinical results.

      research An Analysis on Whether or Not Baldness Can Be Reversed

      January 2017 in “Touro Scholar (Touro College)”
      This review concludes that while hair loss cannot be cured, its progression can often be halted or reversed with continuous use of FDA-approved drugs like finasteride and minoxidil.

      research An Update on Hair Restoration

      1 citations , January 2015 in “Journal of Aesthetic & Reconstructive Surgery”
      This review discusses techniques for harvesting follicular units, medical treatments for androgenetic alopecia, and potential future advancements in hair restoration therapy, but it reports no new clinical results.